Related Experiment Video
Updated: Jun 16, 2026

A Stable Phantom Material for Optical and Acoustic Imaging
Published on: June 16, 2023
The Livermore phantom history and supplementation.
Sandra F Snyder1, Richard J Traub
1Pacific Northwest National Laboratory, Richland, WA 99352, USA. sandra.snyder@pnl.gov
In vivo monitoring facilities use phantoms to accurately detect internally entrained radionuclides. The Lawrence Livermore National Laboratory (LLNL) torso phantom, crucial for low-energy photon detection, is now available with surface scan files online.
Area of Science:
- Nuclear physics and radiation detection.
- Medical physics and health physics.
- Biomonitoring and occupational health.
Background:
- In vivo monitoring facilities are essential for detecting internally deposited radionuclides.
- Accurate quantification requires sensitive detection systems capable of identifying specific nuclides at relevant levels.
- Phantoms are critical tools for calibrating and improving the accuracy of in vivo measurements.
Observation:
- The Lawrence Livermore National Laboratory (LLNL) torso phantom, developed in the 1970s, remains a widely used tool, particularly for low-energy photon detection from transuranic elements.
- This phantom has been instrumental in lung monitoring facilities for assessing internal contamination.
- The historical development, design evolution, and current availability of the LLNL phantom are documented.
Findings:
- The authors have enhanced the utility of the LLNL phantom by performing surface scans.
- Surface scan files of the LLNL phantom are now accessible via the internet.
- This advancement facilitates more precise phantom utilization and data acquisition.
Implications:
- Increased accessibility of phantom scan data can improve the accuracy and standardization of in vivo monitoring.
- Enhanced phantom data supports better calibration of detection systems for transuranic nuclides.
- This resource aids in occupational health and safety by improving the assessment of internal radionuclide exposure.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

